Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli U-M, Erlanson M, Fluge Øystein, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M. Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up. haematol [Internet]. 2024Jul.1 [cited 2024Jul.3];109(7):2359-63. Available from: https://haematologica.org/article/view/haematol.2024.285207